Concinnity is developing an AI-driven RNA design platform to build gene control systems for gene and cell therapies. Our RNA-based control systems will form part of the gene therapy cassette and enable precise control of therapeutic activity. Such control systems have huge potential to enhance both patient safety and therapeutic efficacy, for example by allowing a gene therapy to dynamically adjust its activity in response to patient disease state, recognise tissue type, or by allowing clinical control of the therapy after administration.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Glasgow, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Glasgow
Concinnity Genetics Questions
Concinnity Genetics's website is https://www.concinnitygenetics.com/
Concinnity Genetics's LinkedIn profile is https://uk.linkedin.com/company/concinnity-genetics
Concinnity Genetics has
9 employees.
View email and phone details for 9
employees at Concinnity Genetics.
Concinnity Genetics's industry is
Biotechnology Research
Concinnity Genetics's top competitors are
Centre For Human Specific Research,
Laverock Therapeutics,
Remora,
Cexal,
Edinburgh Innovations,
Excellio,
Eos,
Igii,
Axol Bioscience Ltd.,
Cyanocapture.
Concinnity Genetics's categories are Biotechnology Research
Concinnity Genetics's founding year is 2021
